Gensight Biologics SA is a clinical-stage biotechnology group discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NVDY | 16.71 | 0.19 | +1.15% |
| YieldMax NVDA Option Income Strategy ETF | |||
| OAIM | 38.08 | 0.27 | +0.71% |
| OneAscent International Equity ETF | |||
| PMARX | 12.47 | 0.04 | +0.32% |
| Victory Pioneer Equ Premium Income A | |||
| GDSTX | 25.48 | 0.01 | +0.04% |
| Goldman Sachs Small Cap Eq Insghts Inv | |||
| SIXH | 38.28 | N/A | N/A |
| ETC 6 Meridian Hdg Eq-Idx Opt Strat ETF | |||
A.I.dvisor indicates that over the last year, GSGTF has been loosely correlated with HRTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GSGTF jumps, then HRTX could also see price increases.
| Ticker / NAME | Correlation To GSGTF | 1D Price Change % | ||
|---|---|---|---|---|
| GSGTF | 100% | N/A | ||
| HRTX - GSGTF | 45% Loosely correlated | -0.93% | ||
| RPTX - GSGTF | 34% Loosely correlated | -1.42% | ||
| GOSS - GSGTF | 30% Poorly correlated | -3.85% | ||
| BVAXF - GSGTF | 29% Poorly correlated | N/A | ||
| SPRC - GSGTF | 29% Poorly correlated | +0.72% | ||
More | ||||